Article
Omicron-specific Sinopharm, Sinovac COVID vaccine candidates cleared for clinical trial
Rating:
0.0
Views:
37
Likes:
1
Library:
1
COVID-19 vaccine candidates developed by a Sinopharm and Sinovac Biotech to target the Omicron variant were approved for clinical trials in Hong Kong, the companies said on Saturday.
Rate This Post
-
Education
-
Communication
-
Entertainment
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value